Condition: Iron Deficiency Anemia of Pregnancy · Sponsor: University of Ulster
This study aims to explore how body fat influences the response to either 25 or 50 mg of daily iron supplements during pregnancy. We will conduct a double-blind randomized controlled intervention study involving 312 pregnant women recruited from antenatal clinics in the Northern Trust Area. Participants will be randomly assigned to receive either 25 or 50 mg of iron per day from 12 weeks of pregnancy until delivery, using the Active Iron supplement brand. Blood samples will be collected at 12, 28 and 36 weeks gestation and umbilical cord blood will be collected at delivery. Anthropometric measurements will be taken at each visit, and participants will complete questionnaires on various aspects of health and lifestyle, mental health, gastrointestinal symptoms, and compliance.
This description comes directly from the study's public registry record.
Mary T McCann, PhD · +4402870123969 · mt.mccann@ulster.ac.uk
Ruth Price, PhD · +442870123878 · rk.price@ulster.ac.uk
Always discuss trial participation with your own doctor first.
| Causeway Hospital | Coleraine, Co Londonderry, United Kingdom | Recruiting |
| Causeway Hospital | Coleraine, Co. Londonderry, United Kingdom | Recruiting |
| Ulster University,Human Intervention Studies Unit, | Coleraine, Co. Londonderry, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06425796